Outcomes of hospitalized patients with SARS-CoV-2 infection previously treated with renin-angiotensin system inhibitors

BACKGROUND: Renin angiotensin system inhibitors (RASi) are largely prescribed in hypertensive patients. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) penetrates respiratory epithelium through angiotensin converting enzyme 2 (ACE2) binding, the association between RASi and poorer ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of Cardiovascular Diseases. Supplements
Hauptverfasser: Cordeanu, E., Jambert, L., Lambach, H., Tousch, J., Heitz, M., Mirea, C., Frantz, A.S., Younes, W., Delatte, A., Woehl, B., Bilbault, P., Ohlmann, P., Meziani, F., Andres, E., Stephan, D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Published by Elsevier Masson SAS 2021
Schlagworte:
462
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803093/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.acvdsp.2020.10.143
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge